Comparative effects of Aliskiren and Telmisartan in high fructose diet-induced metabolic syndrome in rats

European Journal of Pharmacology

Volumn 760, Issue , 2015, Pages 145-153

  Rabie, Esraa M ^a   Heeba, Gehan H ^a   Abouzied, Mekky M ^a   Khalifa, Mohamed M A ^a  

^a Minia University   (Egypt)

Author keywords

Aliskiren; Fructose; Insulin resistance; Metabolic syndrome; Telmisartan

Indexed keywords

ALANINE AMINOTRANSFERASE; ALISKIREN; ASPARTATE AMINOTRANSFERASE; CATALASE; FRUCTOSE; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; LIVER ENZYME; MALONALDEHYDE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TELMISARTAN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AMIDE; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; FUMARIC ACID DERIVATIVE; GLUCOSE BLOOD LEVEL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; ENZYME ACTIVITY; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; PHYSIOLOGY; TREATMENT OUTCOME; WISTAR RAT;

AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD GLUCOSE; FRUCTOSE; FUMARATES; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 84929658645     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.04.019     Document Type: Article

References (54)

1. H.H. Arab, M.Y. Al-Shorbagy, D.M. Abdallah, and N.N. Nassar Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease PLoS One 9 2014 e97193
2. K. Araki, T. Masaki, I. Katsuragi, K. Tanaka, T. Kakuma, and H. Yoshimatsu Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice Hypertension 48 2006 51 57
3. S.C. Benson, H.A. Pershadsingh, C.I. Ho, A. Chittiboyina, P. Desai, M. Pravenec, N. Qi, J. Wang, M.A. Avery, and T.W. Kurtz Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR {gamma}-modulating activity Hypertension 43 2004 993 1002
4. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
5. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J. Lab. Clin. Med. 61 1963 882 888
6. J.D. Botezelli, L.T. Cambri, A.C. Ghezzi, R.A. Dalia, F.A. Voltarelli, and M.A. de Mello Fructose-rich diet leads to reduced aerobic capacity and to liver injury in rats Lipids Health Dis. 11 2012 78
7. C.M. Boustany, K. Bharadwaj, A. Daugherty, D.R. Brown, D.C. Randall, and L.A. Cassis Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension Am. J. Physiol. Regul. Integr. Comp. Physiol 287 2004 R943 R949
8. C.L. Chou, Y.H. Lai, T.Y. Lin, T.J. Lee, and T.C. Fang Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats Arch. Med. Sci. 7 2011 882 888
9. C.L. Chou, C.Y. Pang, T.J. Lee, and T.C. Fang Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats Hypertens. Res. 36 2013 123 128
10. A.D. de Kloet, E.G. Krause, and S.C. Woods The renin angiotensin system and the metabolic syndrome Physiol. Behav. 100 2010 525 534
11. A.A. Fouad, A.S. Al-Mulhim, and I. Jresat Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice Toxicology 300 2012 149 157
12. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
13. M.E. Frigolet, N. Torres, and A.R. Tovar The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity J. Nutr. Biochem. 24 2013 2003 2015
14. K. Fujita, M. Yoneda, K. Wada, H. Mawatari, H. Takahashi, H. Kirikoshi, M. Inamori, Y. Nozaki, S. Maeyama, S. Saito, T. Iwasaki, Y. Terauchi, and A. Nakajima Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats Dig. Dis. Sci. 52 2007 3455 3464
15. S. Gandhi, B. Srinivasan, and A.S. Akarte Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats J. Renin Angiotensin Aldosterone Syst. 14 2013 3 13
16. R. Geetha, B. Yogalakshmi, S. Sreeja, K. Bhavani, and C.V. Anuradha Troxerutin suppresses lipid abnormalities in the heart of high-fat-high-fructose diet-fed mice Mol. Cell Biochem. 387 2014 123 134
17. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Arterioscler. Thromb. Vasc. Biol. 24 2004 e13 e18
18. G. Guillemain, M. Loizeau, M. Pincon-Raymond, J. Girard, and A. Leturque The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells J. Cell Sci. 113 2000 841 847
19. J. Habibi, A. Whaley-Connell, M.R. Hayden, V.G. DeMarco, R. Schneider, S.D. Sowers, P. Karuparthi, C.M. Ferrario, and J.R. Sowers Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat Endocrinology 149 2008 5643 5653
20. A. Hassanin, and H.A. Malek Effect of renin inhibition on adipokines in diabetic rats Pak. J. Pharm. Sci. 27 2014 767 772
21. M. Iwai, H. Kanno, Y. Tomono, S. Inaba, I. Senba, M. Furuno, M. Mogi, and M. Horiuchi Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice J. Hypertens. 28 2010 1471 1481
22. R. Kelishadi, M. Mansourian, and M. Heidari-Beni Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis Nutrition 30 2014 503 510
23. S. Kim, H. Wanibuchi, A. Hamaguchi, K. Miura, S. Yamanaka, and H. Iwao Angiotensin blockade improves cardiac and renal complications of type II diabetic rats Hypertension 30 1997 1054 1061
24. M. Knorr, M. Hausding, S. Kroller-Schuhmacher, S. Steven, M. Oelze, T. Heeren, A. Scholz, T. Gori, P. Wenzel, E. Schulz, A. Daiber, and T. Munzel Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan Arterioscler. Thromb. Vasc. Biol. 31 2011 2223 2231
25. M. Kretowicz, R.J. Johnson, T. Ishimoto, T. Nakagawa, and J. Manitius The impact of fructose on renal function and blood pressure Int. J. Nephrol 2011 2011 315879
26. H. Kudo, Y. Yata, T. Takahara, K. Kawai, Y. Nakayama, M. Kanayama, T. Oya, S. Morita, M. Sasahara, D.A. Mann, and T. Sugiyama Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue Liver Int. 29 2009 988 996
27. K.C. Lee, C.C. Chan, Y.Y. Yang, Y.C. Hsieh, Y.H. Huang, and H.C. Lin Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice Eur. J. Clin. Investig. 42 2012 1261 1271
28. K.C. Lee, C.C. Chan, Y.Y. Yang, Y.C. Hsieh, Y.H. Huang, and H.C. Lin Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet PLoS One 8 2013 e77817
29. H. Lu, D.L. Rateri, D.L. Feldman, R.J. Jr, A. Fukamizu, J. Ishida, E.G. Oesterling, L.A. Cassis, and A. Daugherty Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice J. Clin. Investig. 118 2008 984 993
30. N. Mamikutty, Z.C. Thent, S.R. Sapri, N.N. Sahruddin, M.R. Mohd Yusof, and F. Haji Suhaimi The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats Biomed. Res. Int 2014 2014 263897
31. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetology 28 1985 412 419
32. H. Mollnau, M. Oelze, E. Zinssius, M. Hausding, Z. Wu, M. Knorr, J. Ghaemi Kerahrodi, S. Kroller-Schon, T. Jansen, C. Teutsch, C. Foster, H. Li, P. Wenzel, E. Schulz, T. Munzel, and A. Daiber Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats Naunyn Schmiedebergs Arch. Pharmacol. 386 2013 405 419
33. Y. Mori, Y. Itoh, and N. Tajima Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity Am. J. Hypertens. 20 2007 431 436
34. E.K. Naderali, and G. Williams Prolonged endothelial-dependent and -independent arterial dysfunction induced in the rat by short-term feeding with a high-fat, high-sucrose diet Atherosclerosis 166 2003 253 259
35. H. Nakagami, M. Kiomy Osako, F. Nakagami, T. Shimosato, N. Minobe, T. Moritani, M. Shimamura, T. Miyake, H. Shimizu, Y. Takeya, and R. Morishita Prevention and regression of non-alcoholic steatohepatitis (NASH) in a rat model by metabosartan, telmisartan Int. J. Mol. Med. 26 2010 477 481
36. A. Nakano, Y. Hattori, C. Aoki, T. Jojima, and K. Kasai Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma Hypertens. Res. 32 2009 765 769
37. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
38. X. Rong, Y. Li, K. Ebihara, M. Zhao, J. Naowaboot, T. Kusakabe, K. Kuwahara, M. Murray, and K. Nakao Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice Diabetologia 20390403 2010
39. L.G. Sanchez-Lozada, E. Tapia, A. Jimenez, P. Bautista, M. Cristobal, T. Nepomuceno, V. Soto, C. Avila-Casado, T. Nakagawa, R.J. Johnson, J. Herrera-Acosta, and M. Franco Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats Am. J. Physiol. Renal Physiol 292 2007 F423 F429
40. K.V. Sastry, R.P. Moudgal, J. Mohan, J.S. Tyagi, and G.S. Rao Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy Anal. Biochem. 306 2002 79 82
41. T. Shiuchi, M. Iwai, H.S. Li, L. Wu, L.J. Min, J.M. Li, M. Okumura, T.X. Cui, and M. Horiuchi Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice Hypertension 43 2004 1003 1010
42. V.P. Singh, B. Le, R. Khode, K.M. Baker, and R. Kumar Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis Diabetes 57 2008 3297 3306
43. P. Stucchi, V. Cano, M. Ruiz-Gayo, and M.S. Fernandez-Alfonso Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity Br. J. Pharmacol. 158 2009 771 778
44. K. Sugimoto, N.R. Qi, L. Kazdova, M. Pravenec, T. Ogihara, and T.W. Kurtz Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis Hypertension 47 2006 1003 1009
45. T. Takaya, S. Kawashima, M. Shinohara, T. Yamashita, R. Toh, N. Sasaki, N. Inoue, K. Hirata, and M. Yokoyama Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice Atherosclerosis 186 2006 402 410
46. Y. Tamaki, Y. Nakade, T. Yamauchi, Y. Makino, S. Yokohama, M. Okada, K. Aso, H. Kanamori, T. Ohashi, K. Sato, H. Nakao, M. Haneda, and M. Yoneda Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis J. Gastroenterol. 48 2013 491 503
47. L. Tappy, and K.A. Le Does fructose consumption contribute to non-alcoholic fatty liver disease Clin. Res. Hepatol. Gastroenterol 36 2012 554 560
48. Q. Tian, R. Miyazaki, T. Ichiki, I. Imayama, K. Inanaga, H. Ohtsubo, K. Yano, K. Takeda, and K. Sunagawa Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta Hypertension 53 2009 798 804
49. L.T. Tran, V.G. Yuen, and J.H. McNeill The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension Mol. Cell Biochem. 332 2009 145 159
50. T.M. Wallace, J.C. Levy, and D.R. Mathews Use and abuse of HOMA modeling Diabetes Care 27 2004 1487 1495
51. S. Yamagishi, and M. Takeuchi Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property Med. Hypotheses. 64 2005 476 478
52. S.N. Yin, M. Liu, D.Q. Jing, Y.M. Mu, J.M. Lu, and C.Y. Pan Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells Endocr. Res. 39 2014 66 72
53. H. Yoshiji, S. Kuriyama, R. Noguchi, Y. Ikenaka, M. Kitade, K. Kaji, J. Yoshii, K. Yanase, M. Yamazaki, K. Asada, T. Tsujimoto, T. Akahane, M. Uemura, and H. Fukui Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development Hepatol. Res. 36 2006 124 129
54. S. Zelber-Sagi, V. Ratziu, and R. Oren Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence World J. Gastroenterol. 17 2011 3377 3389